Anoro Ellipta is a brand-name inhaler that’s prescribed for long-term chronic obstructive pulmonary disease (COPD) treatment. Anoro Ellipta contains the active ingredients vilanterol and ...
Read the Patient Information Leaflet provided by your pharmacist before you start using this medication and each time you get a refill. Follow the illustrated directions for the proper use of this ...
Microsoft Start Health on MSN17d
What Is Umeclidinium And Common Side EffectsUmeclidinium is a prescription antimuscarinic bronchodilator available in the form of an inhaler device. It is used to treat chronic obstructive pulmonary disease (COPD) and is available in ...
Umeclidinium 62.5mcg, vilanterol 25mcg; per inhalation; dry pwd for oral inhalation. LABA as monotherapy (without ICS) for asthma can increase risk of asthma-related events. Do not initiate in ...
UK pharma giant GlaxoSmithKline (LSE: GSK) and Theravance (Nasdaq: THRX) today announced positive results from three Phase III studies with their combination chronic obstructive pulmonary disease ...
AstraZeneca (AZ), GlaxoSmithKline (GSK), Sanofi, Allergan and Britannia Pharma have been reprimanded for running advertisements that breached the Association of British Pharmaceutical Industry ...
Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a ...
Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and ...
and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M.
The program will be implemented by January 1, 2025. The medicines in scope are Advair Diskus, Advair HFA, Anoro Ellipta, Arnuity Ellipta, Breo Ellipta, Incruse Ellipta, Serevent Diskus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback